Power Alley: In The Merck v. Merck Multi-Billion Dollar Federal Lanham Act Name Spat In Newark, There Will Be Oral Argument Held On May 30, 2025...

The argument that day will be over what sort of limits may be placed on evidence -- to be introduced at some future bench trial date, on which of the two is usurping the other's name and branding.

I suspect the real goal of the oral argument will be to help each side see the weaknesses in its own case, here. That is where the able Senior USDC Judge is heading, I think.

Yes, as I've long said, this case should settle. Neither side should risk losing well-over a century's worth of brand good will, built up in the two iconic pharma names and word marks at right, globally. . . by going to trial. There is much room for a settlement that allows each to move on. But we shall see. Here's the able USDC Judge Salas's order, just entered -- for that May date:

. . .TEXT ORDER:

The Court will hold oral argument on Defendants' motions in limine (D.E. Nos. [261], [262], [264], [268], [269] & [271]) on Friday, 5/30/2025 at 01:00 PM in Newark - Courtroom 5A before Judge Esther Salas.

In the interim, Defendants' motions in limine (D.E. Nos. [261], [262], [264], [268], [269] & [271]) are ADMINISTRATIVELY TERMINATED for docket management purposes only.So Ordered by Judge Esther Salas on 3/27/2025. . . .

Onward, as Kennedy outlines plans to cut about 10,000 positions from Health and Human Services. Damn. That's a setback, for the progress of bio-sciences, and human health care. Just. . . damn.

नमस्ते